Long-term estrogen-only HRT increases the risk of breast cancer
This article has no abstract so we have provided the first paragraph of the full text.
Whether postmenopausal women who use estrogen-only hormone replacement therapy (HRT) have an increased risk of breast cancer is unclear. Lyytinen and colleagues, therefore, investigated the effects of different doses, constituents, and administration routes of estrogen-only HRT on the risk of breast cancer in a cohort of Finnish women.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research HighlightsNature Biotechnology News and Views (01 May 2006)
DisSARMing Toll-like receptor signalingNature Immunology News and Views (01 Oct 2006)
A peppy response to PEPI resultsNature Medicine News and Views (01 Mar 1995)